Bashkim Kadriu
Bashkim Kadriu
National Institute of Mental Health
Verified email at
Cited by
Cited by
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice
F Matrisciano, P Tueting, I Dalal, B Kadriu, DR Grayson, JM Davis, ...
Neuropharmacology 68, 184-194, 2013
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice
RC Agís-Balboa, G Pinna, F Pibiri, B Kadriu, E Costa, A Guidotti
Proceedings of the National Academy of Sciences 104 (47), 18736-18741, 2007
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
M Veldic, B Kadriu, E Maloku, RC Agis-Balboa, A Guidotti, JM Davis, ...
Schizophrenia research 91 (1-3), 51-61, 2007
An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes
A Zhubi, M Veldic, NV Puri, B Kadriu, H Caruncho, I Loza, H Sershen, ...
Schizophrenia research 111 (1-3), 115-122, 2009
Prognosis and improved outcomes in major depression: a review
C Kraus, B Kadriu, R Lanzenberger, CA Zarate Jr, S Kasper
Translational psychiatry 9 (1), 1-17, 2019
Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression
E Maloku, IR Covelo, I Hanbauer, A Guidotti, B Kadriu, Q Hu, JM Davis, ...
Proceedings of the National Academy of Sciences 107 (9), 4407-4411, 2010
Ketamine and beyond: investigations into the potential of glutamatergic agents to treat depression
MS Lener, B Kadriu, CA Zarate
Drugs 77 (4), 381-401, 2017
Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments
B Kadriu, L Musazzi, ID Henter, M Graves, M Popoli, CA Zarate Jr
International Journal of Neuropsychopharmacology 22 (2), 119-135, 2019
DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67‐positive neurons in the GAD67‐GFP mouse brain
B Kadriu, A Guidotti, Y Chen, DR Grayson
Journal of Comparative Neurology 520 (9), 1951-1964, 2012
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales
ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ...
Journal of affective disorders 231, 51-57, 2018
Imidazenil: a low efficacy agonist at α1-but high efficacy at α5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem
J Auta, F Impagnatiello, B Kadriu, A Guidotti, E Costa
Neuropharmacology 55 (2), 148-153, 2008
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
R Moaddel, M Shardell, M Khadeer, J Lovett, B Kadriu, S Ravichandran, ...
Psychopharmacology 235 (10), 3017-3030, 2018
Selective α 4 β 2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons
E Maloku, B Kadriu, A Zhubi, E Dong, F Pibiri, R Satta, A Guidotti
Neuropsychopharmacology 36 (7), 1366-1374, 2011
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ...
Molecular psychiatry 23 (7), 1626-1631, 2018
Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage
B Kadriu, A Guidotti, E Costa, J Auta
Toxicology 256 (3), 164-174, 2009
Characterizing the course of suicidal ideation response to ketamine
ED Ballard, JS Yarrington, CA Farmer, E Richards, R Machado-Vieira, ...
Journal of affective disorders 241, 86-93, 2018
The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice
F Pibiri, AP Kozikowski, G Pinna, J Auta, B Kadriu, E Costa, A Guidotti
Proceedings of the National Academy of Sciences 105 (37), 14169-14174, 2008
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
EE Acevedo-Diaz, GW Cavanaugh, D Greenstein, C Kraus, B Kadriu, ...
Journal of affective disorders 263, 568-575, 2020
Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology
B Kadriu, A Guidotti, E Costa, JM Davis, J Auta
Toxicological sciences 120 (1), 136-145, 2011
The influence of ketamine on drug discovery in depression
C Kraus, D Wasserman, ID Henter, E Acevedo-Diaz, B Kadriu, ...
Drug discovery today 24 (10), 2033-2043, 2019
The system can't perform the operation now. Try again later.
Articles 1–20